As the primary necessity to treat GBM patients is to inhibit the tumor cells from proliferating, we treated U87 and U251 cells with the JAK3 inhibitor WHI-P131 to investigate whether it can effectively block their extensive rate of proliferation. This evidence concerns the gene JAK3 and neoplasm.